Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Methotrexate].

× No keyword cloud information.

49 in total

1. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.

Authors: A Nyfors
Journal: Acta Pathol Microbiol Scand A Date: 1977-07

2. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Authors: R Maini; E W St Clair; F Breedveld; D Furst; J Kalden; M Weisman; J Smolen; P Emery; G Harriman; M Feldmann; P Lipsky
Journal: Lancet Date: 1999-12-04 Impact factor: 79.321

3. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.

Authors: J Aponte; M Petrelli
Journal: Arthritis Rheum Date: 1988-12

4. Methotrexate in the treatment of rheumatoid arthritis; pilot study.

Authors: W S Wilke; L H Calabrese; A L Scherbel
Journal: Cleve Clin Q Date: 1980

5. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.

Authors: R Rau; T Karger; G Herborn; H Frenzel
Journal: J Rheumatol Date: 1989-04 Impact factor: 4.666

6. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis.

Authors: Geertje M Bartelds; Carla A Wijbrandts; Michael T Nurmohamed; Steven Stapel; Willem F Lems; Lucien Aarden; Ben A C Dijkmans; Paul Peter Tak; Gerrit Jan Wolbink
Journal: Ann Rheum Dis Date: 2007-02-14 Impact factor: 19.103

7. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors: Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal: Arthritis Rheum Date: 2006-01

8. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.

Authors: Paul Emery; Roy M Fleischmann; Larry W Moreland; Elizabeth C Hsia; Ingrid Strusberg; Patrick Durez; Peter Nash; Eric Jason B Amante; Melvin Churchill; Won Park; Bernardo Antonio Pons-Estel; Mittie K Doyle; Sudha Visvanathan; Weichun Xu; Mahboob U Rahman
Journal: Arthritis Rheum Date: 2009-08

9. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Authors: Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; Deborah Robertson; Amitabh Singh; Ronald D Pedersen; Andrew S Koenig; Bruce Freundlich
Journal: Lancet Date: 2008-07-16 Impact factor: 79.321

10. Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial.

Authors: Gerd R Burmester; William F Rigby; Ronald F van Vollenhoven; Jonathan Kay; Andrea Rubbert-Roth; Ariella Kelman; Sophie Dimonaco; Nina Mitchell
Journal: Ann Rheum Dis Date: 2015-10-28 Impact factor: 19.103